Search Results for: HIV

5306 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
TP53 and TAF9B tumor protein p53 TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor, 31kDa
  • Cellular Senescence
  • Activation of BH3-only proteins
  • p53-Dependent G1/S DNA damage checkpoint
  • Oncogene Induced Senescence
  • p53-Dependent G1 DNA Damage Response
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
  • Pre-NOTCH Transcription and Translation
  • Stabilization of p53
  • Transcriptional activation of p53 responsive genes
  • Programmed Cell Death
  • Pre-NOTCH Expression and Processing
  • G1/S DNA Damage Checkpoints
  • Intrinsic Pathway for Apoptosis
  • Transcriptional activation of cell cycle inhibitor p21
  • DNA Damage/Telomere Stress Induced Senescence
  • Signaling by NOTCH
  • Factors involved in megakaryocyte development and platelet production
  • Activation of NOXA and translocation to mitochondria
  • Oxidative Stress Induced Senescence
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Activation of PUMA and translocation to mitochondria
  • Cell Cycle Checkpoints
  • RNA Polymerase II Promoter Escape
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase II Transcription
  • HIV Infection
  • RNA Polymerase II Pre-transcription Events
  • Late Phase of HIV Life Cycle
  • HIV Life Cycle
  • HIV Transcription Initiation
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • RNA Polymerase II HIV Promoter Escape
  • RNA Polymerase II Transcription Initiation
  • Transcription of the HIV genome
TP53 and VPRBP tumor protein p53 Vpr (HIV-1) binding protein
  • Cellular Senescence
  • Activation of BH3-only proteins
  • p53-Dependent G1/S DNA damage checkpoint
  • Oncogene Induced Senescence
  • p53-Dependent G1 DNA Damage Response
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
  • Pre-NOTCH Transcription and Translation
  • Stabilization of p53
  • Transcriptional activation of p53 responsive genes
  • Programmed Cell Death
  • Pre-NOTCH Expression and Processing
  • G1/S DNA Damage Checkpoints
  • Intrinsic Pathway for Apoptosis
  • Transcriptional activation of cell cycle inhibitor p21
  • DNA Damage/Telomere Stress Induced Senescence
  • Signaling by NOTCH
  • Factors involved in megakaryocyte development and platelet production
  • Activation of NOXA and translocation to mitochondria
  • Oxidative Stress Induced Senescence
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Activation of PUMA and translocation to mitochondria
  • Cell Cycle Checkpoints
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Class I MHC mediated antigen processing & presentation
  • Adaptive Immune System
TP53 and TSG101 tumor protein p53 tumor susceptibility 101
  • Cellular Senescence
  • Activation of BH3-only proteins
  • p53-Dependent G1/S DNA damage checkpoint
  • Oncogene Induced Senescence
  • p53-Dependent G1 DNA Damage Response
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
  • Pre-NOTCH Transcription and Translation
  • Stabilization of p53
  • Transcriptional activation of p53 responsive genes
  • Programmed Cell Death
  • Pre-NOTCH Expression and Processing
  • G1/S DNA Damage Checkpoints
  • Intrinsic Pathway for Apoptosis
  • Transcriptional activation of cell cycle inhibitor p21
  • DNA Damage/Telomere Stress Induced Senescence
  • Signaling by NOTCH
  • Factors involved in megakaryocyte development and platelet production
  • Activation of NOXA and translocation to mitochondria
  • Oxidative Stress Induced Senescence
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Activation of PUMA and translocation to mitochondria
  • Cell Cycle Checkpoints
  • Assembly Of The HIV Virion
  • Synthesis And Processing Of GAG, GAGPOL Polyproteins
  • HIV Life Cycle
  • Budding and maturation of HIV virion
  • HIV Infection
  • Endosomal Sorting Complex Required For Transport (ESCRT)
  • Membrane binding and targetting of GAG proteins
  • Late Phase of HIV Life Cycle
TP53 and UBB tumor protein p53 ubiquitin B
  • Cellular Senescence
  • Activation of BH3-only proteins
  • p53-Dependent G1/S DNA damage checkpoint
  • Oncogene Induced Senescence
  • p53-Dependent G1 DNA Damage Response
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
  • Pre-NOTCH Transcription and Translation
  • Stabilization of p53
  • Transcriptional activation of p53 responsive genes
  • Programmed Cell Death
  • Pre-NOTCH Expression and Processing
  • G1/S DNA Damage Checkpoints
  • Intrinsic Pathway for Apoptosis
  • Transcriptional activation of cell cycle inhibitor p21
  • DNA Damage/Telomere Stress Induced Senescence
  • Signaling by NOTCH
  • Factors involved in megakaryocyte development and platelet production
  • Activation of NOXA and translocation to mitochondria
  • Oxidative Stress Induced Senescence
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Activation of PUMA and translocation to mitochondria
  • Cell Cycle Checkpoints
  • Loss of Function of TGFBR2 in Cancer
  • NF-kB is activated and signals survival
  • Signaling by FGFR in disease
  • Hedgehog 'off' state
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Glucose metabolism
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Signaling by NOTCH1
  • Signaling by NOTCH2
  • Toll Like Receptor 5 (TLR5) Cascade
  • AXIN mutants destabilize the destruction complex, activating WNT signaling
  • S33 mutants of beta-catenin aren't phosphorylated
  • Stabilization of p53
  • Removal of licensing factors from origins
  • Switching of origins to a post-replicative state
  • Downregulation of ERBB2:ERBB3 signaling
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • Signaling by NOTCH
  • Endosomal Sorting Complex Required For Transport (ESCRT)
  • Spry regulation of FGF signaling
  • Signaling by NOTCH
  • SCF(Skp2)-mediated degradation of p27/p21
  • deletions in the AMER1 gene destabilize the destruction complex
  • Regulation of innate immune responses to cytosolic DNA
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Toll Like Receptor 3 (TLR3) Cascade
  • Metabolism of carbohydrates
  • CDK-mediated phosphorylation and removal of Cdc6
  • Cellular response to hypoxia
  • Hedgehog ligand biogenesis
  • p75NTR recruits signalling complexes
  • Fanconi Anemia pathway
  • Separation of Sister Chromatids
  • HIV Infection
  • APC truncation mutants have impaired AXIN binding
  • Assembly of the pre-replicative complex
  • Synthesis And Processing Of GAG, GAGPOL Polyproteins
  • Activated TLR4 signalling
  • S37 mutants of beta-catenin aren't phosphorylated
  • p53-Dependent G1 DNA Damage Response
  • regulation of FZD by ubiquitination
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Signaling by NOTCH1
  • p53-Independent DNA Damage Response
  • MyD88:Mal cascade initiated on plasma membrane
  • Stimuli-sensing channels
  • Membrane binding and targetting of GAG proteins
  • p53-Independent G1/S DNA damage checkpoint
  • G1/S DNA Damage Checkpoints
  • Downregulation of ERBB4 signaling
  • Vpu mediated degradation of CD4
  • Cell death signalling via NRAGE, NRIF and NADE
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • M/G1 Transition
  • p75 NTR receptor-mediated signalling
  • Signaling by FGFR
  • Toll Like Receptor 10 (TLR10) Cascade
  • Signaling by NOTCH1 in Cancer
  • TCF dependent signaling in response to WNT
  • SCF-beta-TrCP mediated degradation of Emi1
  • degradation of AXIN
  • Degradation of GLI1 by the proteasome
  • degradation of DVL
  • Cell Cycle Checkpoints
  • Signaling by WNT in cancer
  • GLI3 is processed to GLI3R by the proteasome
  • Regulation of Apoptosis
  • Degradation of GLI2 by the proteasome
  • Signaling by the B Cell Receptor (BCR)
  • Vif-mediated degradation of APOBEC3G
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Constitutive Signaling by NOTCH1 HD Domain Mutants
  • Downregulation of TGF-beta receptor signaling
  • truncated APC mutants destabilize the destruction complex
  • Cyclin E associated events during G1/S transition
  • TGF-beta receptor signaling activates SMADs
  • Regulation of PLK1 Activity at G2/M Transition
  • FCERI mediated NF-kB activation
  • Regulation of the Fanconi anemia pathway
  • Generic Transcription Pathway
  • G1/S Transition
  • Toll Like Receptor 9 (TLR9) Cascade
  • FBXW7 Mutants and NOTCH1 in Cancer
  • IRAK1 recruits IKK complex
  • Negative regulation of FGFR signaling
  • truncations of AMER1 destabilize the destruction complex
  • EGFR downregulation
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • IRAK2 mediated activation of TAK1 complex
  • Processing-defective Hh variants abrogate ligand secretion
  • Regulation of activated PAK-2p34 by proteasome mediated degradation
  • Host Interactions of HIV factors
  • phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
  • Signaling by ERBB4
  • Antiviral mechanism by IFN-stimulated genes
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Interleukin-3, 5 and GM-CSF signaling
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • M Phase
  • APC truncation mutants are not K63 polyubiquitinated
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
  • HIV Life Cycle
  • Budding and maturation of HIV virion
  • Hedgehog 'on' state
  • Programmed Cell Death
  • Class I MHC mediated antigen processing & presentation
  • IKK complex recruitment mediated by RIP1
  • MAP kinase activation in TLR cascade
  • Regulation of DNA replication
  • Cytokine Signaling in Immune system
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • MyD88-independent cascade
  • Cell Cycle, Mitotic
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Oxidative Stress Induced Senescence
  • Activation of NF-kappaB in B cells
  • Asymmetric localization of PCP proteins
  • deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling
  • TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling
  • IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
  • TRAF6 mediated induction of TAK1 complex
  • Negative regulators of RIG-I/MDA5 signaling
  • misspliced GSK3beta mutants stabilize beta-catenin
  • Hh ligand biogenesis disease
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • T41 mutants of beta-catenin aren't phosphorylated
  • Cellular Senescence
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by EGFRvIII in Cancer
  • Assembly Of The HIV Virion
  • Downstream signaling events of B Cell Receptor (BCR)
  • Degradation of beta-catenin by the destruction complex
  • NOD1/2 Signaling Pathway
  • Glycogen storage diseases
  • MyD88 dependent cascade initiated on endosome
  • Mitotic G1-G1/S phases
  • activated TAK1 mediates p38 MAPK activation
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • TRIF-mediated TLR3/TLR4 signaling
  • DNA Replication Pre-Initiation
  • Senescence-Associated Secretory Phenotype (SASP)
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • TGFBR1 KD Mutants in Cancer
  • S45 mutants of beta-catenin aren't phosphorylated
  • Regulation of APC/C activators between G1/S and early anaphase
  • Late Phase of HIV Life Cycle
  • APC/C:Cdc20 mediated degradation of Cyclin B
  • NOTCH2 Activation and Transmission of Signal to the Nucleus
  • TCR signaling
  • AMER1 mutants destabilize the destruction complex
  • Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
  • Interleukin-1 signaling
  • APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
  • PCP/CE pathway
  • Mitotic G2-G2/M phases
  • Adaptive Immune System
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Regulation of Hypoxia-inducible Factor (HIF) by oxygen
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • Ubiquitin-dependent degradation of Cyclin D
  • G2/M Transition
  • TGFBR1 LBD Mutants in Cancer
  • Oncogene Induced Senescence
  • Autodegradation of Cdh1 by Cdh1:APC/C
  • Ion channel transport
  • p75NTR signals via NF-kB
  • Regulation of signaling by CBL
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Disease
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Signal Transduction
  • Innate Immune System
  • Synthesis of DNA
  • Loss of Function of SMAD2/3 in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • G1 Phase
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • Loss of Function of TGFBR1 in Cancer
  • Ubiquitin-dependent degradation of Cyclin D1
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Toll-Like Receptors Cascades
  • Cyclin D associated events in G1
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • Regulation of mitotic cell cycle
  • Signaling by Hedgehog
  • Association of licensing factors with the pre-replicative complex
  • IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
  • Ubiquitin Mediated Degradation of Phosphorylated Cdc25A
  • TCF7L2 mutants don't bind CTBP
  • p53-Dependent G1/S DNA damage checkpoint
  • Signaling by Wnt
  • AUF1 (hnRNP D0) destabilizes mRNA
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • APC/C:Cdc20 mediated degradation of Securin
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • CDK-mediated phosphorylation and removal of Cdc6
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • IRAK1 recruits IKK complex
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • RNF mutants show enhanced WNT signaling and proliferation
  • Myoclonic epilepsy of Lafora
  • Signaling by NOTCH1 in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • IRAK2 mediated activation of TAK1 complex
  • Loss of Function of SMAD4 in Cancer
  • AXIN missense mutants destabilize the destruction complex
  • S Phase
  • APC/C-mediated degradation of cell cycle proteins
  • Toll Like Receptor 2 (TLR2) Cascade
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by Interleukins
  • Glycogen synthesis
  • NRIF signals cell death from the nucleus
  • Toll Like Receptor 4 (TLR4) Cascade
  • Signaling by EGFR in Cancer
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • SCF(Skp2)-mediated degradation of p27/p21
  • Cyclin A:Cdk2-associated events at S phase entry
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Mitotic Metaphase and Anaphase
  • Downstream TCR signaling
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Orc1 removal from chromatin
  • Mitotic Anaphase
  • deactivation of the beta-catenin transactivating complex
  • Toll Like Receptor TLR6:TLR2 Cascade
  • MyD88 cascade initiated on plasma membrane
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • FBXW7 Mutants and NOTCH1 in Cancer
  • JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
  • Signalling by NGF
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Cytosolic sensors of pathogen-associated DNA
  • beta-catenin independent WNT signaling
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Orc1 removal from chromatin
  • Signaling by TGF-beta Receptor Complex
  • CDT1 association with the CDC6:ORC:origin complex
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • SMAD4 MH2 Domain Mutants in Cancer
TP53 and NMT2 tumor protein p53 N-myristoyltransferase 2
  • Cellular Senescence
  • Activation of BH3-only proteins
  • p53-Dependent G1/S DNA damage checkpoint
  • Oncogene Induced Senescence
  • p53-Dependent G1 DNA Damage Response
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
  • Pre-NOTCH Transcription and Translation
  • Stabilization of p53
  • Transcriptional activation of p53 responsive genes
  • Programmed Cell Death
  • Pre-NOTCH Expression and Processing
  • G1/S DNA Damage Checkpoints
  • Intrinsic Pathway for Apoptosis
  • Transcriptional activation of cell cycle inhibitor p21
  • DNA Damage/Telomere Stress Induced Senescence
  • Signaling by NOTCH
  • Factors involved in megakaryocyte development and platelet production
  • Activation of NOXA and translocation to mitochondria
  • Oxidative Stress Induced Senescence
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Activation of PUMA and translocation to mitochondria
  • Cell Cycle Checkpoints
  • Assembly Of The HIV Virion
  • Synthesis And Processing Of GAG, GAGPOL Polyproteins
  • Inactivation, recovery and regulation of the phototransduction cascade
  • HIV Life Cycle
  • Visual phototransduction
  • The phototransduction cascade
  • HIV Infection
  • Diseases associated with visual transduction
  • Membrane binding and targetting of GAG proteins
  • Late Phase of HIV Life Cycle
TP53 and PSME3 tumor protein p53 proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki)
  • Cellular Senescence
  • Activation of BH3-only proteins
  • p53-Dependent G1/S DNA damage checkpoint
  • Oncogene Induced Senescence
  • p53-Dependent G1 DNA Damage Response
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
  • Pre-NOTCH Transcription and Translation
  • Stabilization of p53
  • Transcriptional activation of p53 responsive genes
  • Programmed Cell Death
  • Pre-NOTCH Expression and Processing
  • G1/S DNA Damage Checkpoints
  • Intrinsic Pathway for Apoptosis
  • Transcriptional activation of cell cycle inhibitor p21
  • DNA Damage/Telomere Stress Induced Senescence
  • Signaling by NOTCH
  • Factors involved in megakaryocyte development and platelet production
  • Activation of NOXA and translocation to mitochondria
  • Oxidative Stress Induced Senescence
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Activation of PUMA and translocation to mitochondria
  • Cell Cycle Checkpoints
  • Hedgehog 'off' state
  • misspliced GSK3beta mutants stabilize beta-catenin
  • Hh ligand biogenesis disease
  • T41 mutants of beta-catenin aren't phosphorylated
  • Downstream signaling events of B Cell Receptor (BCR)
  • Degradation of beta-catenin by the destruction complex
  • Stabilization of p53
  • S33 mutants of beta-catenin aren't phosphorylated
  • AXIN mutants destabilize the destruction complex, activating WNT signaling
  • Removal of licensing factors from origins
  • Switching of origins to a post-replicative state
  • Mitotic G1-G1/S phases
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • DNA Replication Pre-Initiation
  • S45 mutants of beta-catenin aren't phosphorylated
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • Regulation of APC/C activators between G1/S and early anaphase
  • SCF(Skp2)-mediated degradation of p27/p21
  • deletions in the AMER1 gene destabilize the destruction complex
  • Autodegradation of the E3 ubiquitin ligase COP1
  • AMER1 mutants destabilize the destruction complex
  • Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
  • APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
  • PCP/CE pathway
  • Adaptive Immune System
  • CDK-mediated phosphorylation and removal of Cdc6
  • Hedgehog ligand biogenesis
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Separation of Sister Chromatids
  • HIV Infection
  • Ubiquitin-dependent degradation of Cyclin D
  • APC truncation mutants have impaired AXIN binding
  • Assembly of the pre-replicative complex
  • Autodegradation of Cdh1 by Cdh1:APC/C
  • p53-Dependent G1 DNA Damage Response
  • S37 mutants of beta-catenin aren't phosphorylated
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • p53-Independent DNA Damage Response
  • p53-Independent G1/S DNA damage checkpoint
  • G1/S DNA Damage Checkpoints
  • Vpu mediated degradation of CD4
  • Synthesis of DNA
  • M/G1 Transition
  • Ubiquitin-dependent degradation of Cyclin D1
  • TCF dependent signaling in response to WNT
  • SCF-beta-TrCP mediated degradation of Emi1
  • degradation of AXIN
  • Signaling by Hedgehog
  • Regulation of mitotic cell cycle
  • Degradation of GLI1 by the proteasome
  • degradation of DVL
  • Cell Cycle Checkpoints
  • Signaling by WNT in cancer
  • GLI3 is processed to GLI3R by the proteasome
  • Regulation of Apoptosis
  • Degradation of GLI2 by the proteasome
  • Signaling by the B Cell Receptor (BCR)
  • Vif-mediated degradation of APOBEC3G
  • Ubiquitin Mediated Degradation of Phosphorylated Cdc25A
  • p53-Dependent G1/S DNA damage checkpoint
  • truncated APC mutants destabilize the destruction complex
  • TCF7L2 mutants don't bind CTBP
  • Signaling by Wnt
  • Cyclin E associated events during G1/S transition
  • APC/C:Cdc20 mediated degradation of Securin
  • AUF1 (hnRNP D0) destabilizes mRNA
  • CDK-mediated phosphorylation and removal of Cdc6
  • RNF mutants show enhanced WNT signaling and proliferation
  • G1/S Transition
  • truncations of AMER1 destabilize the destruction complex
  • Processing-defective Hh variants abrogate ligand secretion
  • Host Interactions of HIV factors
  • phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
  • Regulation of activated PAK-2p34 by proteasome mediated degradation
  • AXIN missense mutants destabilize the destruction complex
  • S Phase
  • APC/C-mediated degradation of cell cycle proteins
  • Cyclin A:Cdk2-associated events at S phase entry
  • SCF(Skp2)-mediated degradation of p27/p21
  • Mitotic Metaphase and Anaphase
  • Regulation of ornithine decarboxylase (ODC)
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Orc1 removal from chromatin
  • Mitotic Anaphase
  • M Phase
  • APC truncation mutants are not K63 polyubiquitinated
  • Metabolism of amino acids and derivatives
  • Hedgehog 'on' state
  • Programmed Cell Death
  • Class I MHC mediated antigen processing & presentation
  • Regulation of DNA replication
  • Cell Cycle, Mitotic
  • beta-catenin independent WNT signaling
  • Orc1 removal from chromatin
  • Activation of NF-kappaB in B cells
  • Asymmetric localization of PCP proteins
  • deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling
  • Cross-presentation of soluble exogenous antigens (endosomes)
  • Antigen processing-Cross presentation
  • CDT1 association with the CDC6:ORC:origin complex
  • ER-Phagosome pathway
TP53 and ELL tumor protein p53 elongation factor RNA polymerase II
  • Cellular Senescence
  • Activation of BH3-only proteins
  • p53-Dependent G1/S DNA damage checkpoint
  • Oncogene Induced Senescence
  • p53-Dependent G1 DNA Damage Response
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
  • Pre-NOTCH Transcription and Translation
  • Stabilization of p53
  • Transcriptional activation of p53 responsive genes
  • Programmed Cell Death
  • Pre-NOTCH Expression and Processing
  • G1/S DNA Damage Checkpoints
  • Intrinsic Pathway for Apoptosis
  • Transcriptional activation of cell cycle inhibitor p21
  • DNA Damage/Telomere Stress Induced Senescence
  • Signaling by NOTCH
  • Factors involved in megakaryocyte development and platelet production
  • Activation of NOXA and translocation to mitochondria
  • Oxidative Stress Induced Senescence
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Activation of PUMA and translocation to mitochondria
  • Cell Cycle Checkpoints
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • RNA Polymerase II Transcription
  • HIV Infection
  • Tat-mediated elongation of the HIV-1 transcript
  • Tat-mediated HIV elongation arrest and recovery
  • RNA Polymerase II Pre-transcription Events
  • Late Phase of HIV Life Cycle
  • Pausing and recovery of Tat-mediated HIV elongation
  • Formation of RNA Pol II elongation complex
  • HIV elongation arrest and recovery
  • HIV Life Cycle
  • Pausing and recovery of HIV elongation
  • Formation of HIV elongation complex in the absence of HIV Tat
  • HIV Transcription Elongation
  • Transcription of the HIV genome
  • RNA Polymerase II Transcription Elongation
CDKN2A and PSMC3 cyclin-dependent kinase inhibitor 2A proteasome (prosome, macropain) 26S subunit, ATPase, 3
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • Hedgehog 'off' state
  • misspliced GSK3beta mutants stabilize beta-catenin
  • Hh ligand biogenesis disease
  • T41 mutants of beta-catenin aren't phosphorylated
  • Downstream signaling events of B Cell Receptor (BCR)
  • Degradation of beta-catenin by the destruction complex
  • Stabilization of p53
  • S33 mutants of beta-catenin aren't phosphorylated
  • AXIN mutants destabilize the destruction complex, activating WNT signaling
  • Removal of licensing factors from origins
  • Switching of origins to a post-replicative state
  • Mitotic G1-G1/S phases
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • DNA Replication Pre-Initiation
  • S45 mutants of beta-catenin aren't phosphorylated
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • Regulation of APC/C activators between G1/S and early anaphase
  • SCF(Skp2)-mediated degradation of p27/p21
  • deletions in the AMER1 gene destabilize the destruction complex
  • Autodegradation of the E3 ubiquitin ligase COP1
  • AMER1 mutants destabilize the destruction complex
  • Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
  • APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
  • PCP/CE pathway
  • Adaptive Immune System
  • CDK-mediated phosphorylation and removal of Cdc6
  • Hedgehog ligand biogenesis
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Separation of Sister Chromatids
  • HIV Infection
  • Ubiquitin-dependent degradation of Cyclin D
  • APC truncation mutants have impaired AXIN binding
  • Assembly of the pre-replicative complex
  • Autodegradation of Cdh1 by Cdh1:APC/C
  • p53-Dependent G1 DNA Damage Response
  • S37 mutants of beta-catenin aren't phosphorylated
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • p53-Independent DNA Damage Response
  • p53-Independent G1/S DNA damage checkpoint
  • G1/S DNA Damage Checkpoints
  • Vpu mediated degradation of CD4
  • Synthesis of DNA
  • M/G1 Transition
  • Ubiquitin-dependent degradation of Cyclin D1
  • TCF dependent signaling in response to WNT
  • SCF-beta-TrCP mediated degradation of Emi1
  • degradation of AXIN
  • Signaling by Hedgehog
  • Regulation of mitotic cell cycle
  • Degradation of GLI1 by the proteasome
  • degradation of DVL
  • Cell Cycle Checkpoints
  • Signaling by WNT in cancer
  • GLI3 is processed to GLI3R by the proteasome
  • Regulation of Apoptosis
  • Degradation of GLI2 by the proteasome
  • Signaling by the B Cell Receptor (BCR)
  • Vif-mediated degradation of APOBEC3G
  • Ubiquitin Mediated Degradation of Phosphorylated Cdc25A
  • p53-Dependent G1/S DNA damage checkpoint
  • truncated APC mutants destabilize the destruction complex
  • TCF7L2 mutants don't bind CTBP
  • Signaling by Wnt
  • Cyclin E associated events during G1/S transition
  • APC/C:Cdc20 mediated degradation of Securin
  • AUF1 (hnRNP D0) destabilizes mRNA
  • CDK-mediated phosphorylation and removal of Cdc6
  • RNF mutants show enhanced WNT signaling and proliferation
  • G1/S Transition
  • truncations of AMER1 destabilize the destruction complex
  • Processing-defective Hh variants abrogate ligand secretion
  • Host Interactions of HIV factors
  • phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
  • Regulation of activated PAK-2p34 by proteasome mediated degradation
  • AXIN missense mutants destabilize the destruction complex
  • S Phase
  • APC/C-mediated degradation of cell cycle proteins
  • Cyclin A:Cdk2-associated events at S phase entry
  • SCF(Skp2)-mediated degradation of p27/p21
  • Mitotic Metaphase and Anaphase
  • Regulation of ornithine decarboxylase (ODC)
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Orc1 removal from chromatin
  • Mitotic Anaphase
  • M Phase
  • APC truncation mutants are not K63 polyubiquitinated
  • Metabolism of amino acids and derivatives
  • Hedgehog 'on' state
  • Programmed Cell Death
  • Class I MHC mediated antigen processing & presentation
  • Regulation of DNA replication
  • Cell Cycle, Mitotic
  • beta-catenin independent WNT signaling
  • Orc1 removal from chromatin
  • Activation of NF-kappaB in B cells
  • Asymmetric localization of PCP proteins
  • deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling
  • Cross-presentation of soluble exogenous antigens (endosomes)
  • Antigen processing-Cross presentation
  • CDT1 association with the CDC6:ORC:origin complex
  • ER-Phagosome pathway
KRAS and PSMA3 Kirsten rat sarcoma viral oncogene homolog proteasome (prosome, macropain) subunit, alpha type, 3
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Signaling by FGFR in disease
  • SHC-mediated cascade
  • MEK activation
  • FCERI mediated MAPK activation
  • Signaling by EGFRvIII in Cancer
  • SHC1 events in ERBB2 signaling
  • Signaling by SCF-KIT
  • Downstream signaling events of B Cell Receptor (BCR)
  • DAP12 signaling
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • p38MAPK events
  • SOS-mediated signalling
  • SHC-mediated signalling
  • Signaling by PDGF
  • DAP12 interactions
  • SHC-related events triggered by IGF1R
  • GRB2 events in EGFR signaling
  • Signaling by ERBB4
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by Interleukins
  • SHC1 events in ERBB4 signaling
  • Signaling by VEGF
  • Downstream signal transduction
  • Signalling to RAS
  • Signaling by FGFR mutants
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Interleukin-2 signaling
  • Frs2-mediated activation
  • Signaling by Leptin
  • Adaptive Immune System
  • Signalling to ERKs
  • Prolonged ERK activation events
  • Axon guidance
  • IRS-mediated signalling
  • IGF1R signaling cascade
  • VEGFA-VEGFR2 Pathway
  • IRS-related events triggered by IGF1R
  • EGFR Transactivation by Gastrin
  • GRB2 events in ERBB2 signaling
  • VEGFR2 mediated cell proliferation
  • RAF phosphorylates MEK
  • Downstream signaling of activated FGFR
  • NCAM signaling for neurite out-growth
  • RAF/MAP kinase cascade
  • Signalling to p38 via RIT and RIN
  • Signaling by Insulin receptor
  • Innate Immune System
  • Signalling by NGF
  • Insulin receptor signalling cascade
  • SOS-mediated signalling
  • SHC-mediated signalling
  • Cytokine Signaling in Immune system
  • IRS-related events
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • SHC-related events
  • NGF signalling via TRKA from the plasma membrane
  • Tie2 Signaling
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Cell surface interactions at the vascular wall
  • Signaling by FGFR
  • ARMS-mediated activation
  • RAF activation
  • SHC1 events in EGFR signaling
  • IRS-mediated signalling
  • Activation of RAS in B cells
  • FRS2-mediated cascade
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • Constitutive Signaling by EGFRvIII
  • Hedgehog 'off' state
  • misspliced GSK3beta mutants stabilize beta-catenin
  • Hh ligand biogenesis disease
  • T41 mutants of beta-catenin aren't phosphorylated
  • Downstream signaling events of B Cell Receptor (BCR)
  • Degradation of beta-catenin by the destruction complex
  • Stabilization of p53
  • S33 mutants of beta-catenin aren't phosphorylated
  • AXIN mutants destabilize the destruction complex, activating WNT signaling
  • Removal of licensing factors from origins
  • Switching of origins to a post-replicative state
  • Mitotic G1-G1/S phases
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • DNA Replication Pre-Initiation
  • S45 mutants of beta-catenin aren't phosphorylated
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • Regulation of APC/C activators between G1/S and early anaphase
  • SCF(Skp2)-mediated degradation of p27/p21
  • deletions in the AMER1 gene destabilize the destruction complex
  • Autodegradation of the E3 ubiquitin ligase COP1
  • AMER1 mutants destabilize the destruction complex
  • Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
  • APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
  • PCP/CE pathway
  • Adaptive Immune System
  • CDK-mediated phosphorylation and removal of Cdc6
  • Hedgehog ligand biogenesis
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Separation of Sister Chromatids
  • HIV Infection
  • Ubiquitin-dependent degradation of Cyclin D
  • APC truncation mutants have impaired AXIN binding
  • Assembly of the pre-replicative complex
  • Autodegradation of Cdh1 by Cdh1:APC/C
  • p53-Dependent G1 DNA Damage Response
  • S37 mutants of beta-catenin aren't phosphorylated
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • p53-Independent DNA Damage Response
  • p53-Independent G1/S DNA damage checkpoint
  • G1/S DNA Damage Checkpoints
  • Vpu mediated degradation of CD4
  • Synthesis of DNA
  • M/G1 Transition
  • Ubiquitin-dependent degradation of Cyclin D1
  • TCF dependent signaling in response to WNT
  • SCF-beta-TrCP mediated degradation of Emi1
  • degradation of AXIN
  • Signaling by Hedgehog
  • Regulation of mitotic cell cycle
  • Degradation of GLI1 by the proteasome
  • degradation of DVL
  • Cell Cycle Checkpoints
  • Signaling by WNT in cancer
  • GLI3 is processed to GLI3R by the proteasome
  • Regulation of Apoptosis
  • Degradation of GLI2 by the proteasome
  • Signaling by the B Cell Receptor (BCR)
  • Vif-mediated degradation of APOBEC3G
  • Ubiquitin Mediated Degradation of Phosphorylated Cdc25A
  • p53-Dependent G1/S DNA damage checkpoint
  • truncated APC mutants destabilize the destruction complex
  • TCF7L2 mutants don't bind CTBP
  • Signaling by Wnt
  • Cyclin E associated events during G1/S transition
  • APC/C:Cdc20 mediated degradation of Securin
  • AUF1 (hnRNP D0) destabilizes mRNA
  • CDK-mediated phosphorylation and removal of Cdc6
  • RNF mutants show enhanced WNT signaling and proliferation
  • G1/S Transition
  • truncations of AMER1 destabilize the destruction complex
  • Processing-defective Hh variants abrogate ligand secretion
  • Host Interactions of HIV factors
  • phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
  • Regulation of activated PAK-2p34 by proteasome mediated degradation
  • AXIN missense mutants destabilize the destruction complex
  • S Phase
  • APC/C-mediated degradation of cell cycle proteins
  • Cyclin A:Cdk2-associated events at S phase entry
  • SCF(Skp2)-mediated degradation of p27/p21
  • Mitotic Metaphase and Anaphase
  • Regulation of ornithine decarboxylase (ODC)
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Orc1 removal from chromatin
  • Mitotic Anaphase
  • M Phase
  • APC truncation mutants are not K63 polyubiquitinated
  • Metabolism of amino acids and derivatives
  • Hedgehog 'on' state
  • Programmed Cell Death
  • Class I MHC mediated antigen processing & presentation
  • Regulation of DNA replication
  • Cell Cycle, Mitotic
  • beta-catenin independent WNT signaling
  • Orc1 removal from chromatin
  • Activation of NF-kappaB in B cells
  • Asymmetric localization of PCP proteins
  • deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling
  • Cross-presentation of soluble exogenous antigens (endosomes)
  • Antigen processing-Cross presentation
  • CDT1 association with the CDC6:ORC:origin complex
  • ER-Phagosome pathway
MYC and TBP v-myc avian myelocytomatosis viral oncogene homolog TATA box binding protein
  • Loss of Function of TGFBR2 in Cancer
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Signaling by Wnt
  • Cyclin E associated events during G1/S transition
  • binding of TCF/LEF:CTNNB1 to target gene promoters
  • TGFBR1 LBD Mutants in Cancer
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Generic Transcription Pathway
  • RNF mutants show enhanced WNT signaling and proliferation
  • G1/S Transition
  • Signaling by NOTCH1
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Mitotic G1-G1/S phases
  • FBXW7 Mutants and NOTCH1 in Cancer
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Loss of Function of SMAD2/3 in Cancer
  • Signaling by NOTCH
  • formation of the beta-catenin:TCF transactivating complex
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • S Phase
  • Cell Cycle, Mitotic
  • Loss of Function of TGFBR1 in Cancer
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • TCF dependent signaling in response to WNT
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Cyclin A:Cdk2-associated events at S phase entry
  • Signaling by WNT in cancer
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • SMAD4 MH2 Domain Mutants in Cancer
  • RNA Polymerase II Promoter Escape
  • RNA Polymerase III Transcription Initiation From Type 3 Promoter
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase I Chain Elongation
  • RNA Polymerase II Transcription
  • RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription
  • RNA Polymerase I Transcription Initiation
  • RNA Polymerase I Promoter Clearance
  • HIV Infection
  • RNA Polymerase II Pre-transcription Events
  • HIV Life Cycle
  • HIV Transcription Initiation
  • NoRC negatively regulates rRNA expression
  • RNA Polymerase II HIV Promoter Escape
  • RNA Polymerase III Transcription Initiation
  • RNA Polymerase III Transcription
  • RNA Polymerase III Transcription Initiation From Type 1 Promoter
  • RNA Polymerase I Transcription
  • RNA Polymerase I Transcription Termination
  • RNA Polymerase I Promoter Escape
  • Epigenetic regulation of gene expression
  • Negative epigenetic regulation of rRNA expression
  • Late Phase of HIV Life Cycle
  • RNA Polymerase III Transcription Initiation From Type 2 Promoter
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • RNA Polymerase III Abortive And Retractive Initiation
  • RNA Polymerase II Transcription Initiation
  • SIRT1 negatively regulates rRNA Expression
  • Transcription of the HIV genome
CCNH and MYC cyclin H v-myc avian myelocytomatosis viral oncogene homolog
  • RNA Polymerase II Promoter Escape
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase I Chain Elongation
  • RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription
  • Tat-mediated elongation of the HIV-1 transcript
  • Cyclin E associated events during G1/S transition
  • Formation of transcription-coupled NER (TC-NER) repair complex
  • Dual incision reaction in TC-NER
  • NoRC negatively regulates rRNA expression
  • G1/S Transition
  • Mitotic G1-G1/S phases
  • S Phase
  • Late Phase of HIV Life Cycle
  • Formation of RNA Pol II elongation complex
  • Global Genomic NER (GG-NER)
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • Cyclin A:Cdk2-associated events at S phase entry
  • Mitotic G2-G2/M phases
  • Transcription of the HIV genome
  • Nucleotide Excision Repair
  • RNA Polymerase II Transcription
  • RNA Polymerase I Transcription Initiation
  • HIV Infection
  • RNA Polymerase I Promoter Clearance
  • Formation of the Early Elongation Complex
  • G2/M Transition
  • RNA Pol II CTD phosphorylation and interaction with CE
  • RNA Polymerase II Pre-transcription Events
  • HIV Transcription Initiation
  • HIV Life Cycle
  • RNA Pol II CTD phosphorylation and interaction with CE
  • Cyclin A/B1 associated events during G2/M transition
  • RNA Polymerase II HIV Promoter Escape
  • HIV Transcription Elongation
  • Dual incision reaction in GG-NER
  • RNA Polymerase I Transcription
  • mRNA Capping
  • RNA Polymerase I Promoter Escape
  • RNA Polymerase I Transcription Termination
  • G1 Phase
  • Epigenetic regulation of gene expression
  • Negative epigenetic regulation of rRNA expression
  • Cell Cycle, Mitotic
  • Cyclin D associated events in G1
  • Transcription-coupled NER (TC-NER)
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of the HIV-1 Early Elongation Complex
  • Formation of incision complex in GG-NER
  • RNA Polymerase II Transcription Initiation
  • RNA Polymerase II Transcription Elongation
  • Loss of Function of TGFBR2 in Cancer
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Signaling by Wnt
  • Cyclin E associated events during G1/S transition
  • binding of TCF/LEF:CTNNB1 to target gene promoters
  • TGFBR1 LBD Mutants in Cancer
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Generic Transcription Pathway
  • RNF mutants show enhanced WNT signaling and proliferation
  • G1/S Transition
  • Signaling by NOTCH1
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Mitotic G1-G1/S phases
  • FBXW7 Mutants and NOTCH1 in Cancer
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Loss of Function of SMAD2/3 in Cancer
  • Signaling by NOTCH
  • formation of the beta-catenin:TCF transactivating complex
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • S Phase
  • Cell Cycle, Mitotic
  • Loss of Function of TGFBR1 in Cancer
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • TCF dependent signaling in response to WNT
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Cyclin A:Cdk2-associated events at S phase entry
  • Signaling by WNT in cancer
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • SMAD4 MH2 Domain Mutants in Cancer
CCNT1 and MYC cyclin T1 v-myc avian myelocytomatosis viral oncogene homolog
  • Loss of Function of TGFBR2 in Cancer
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • RNA Polymerase II Transcription
  • HIV Infection
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Tat-mediated elongation of the HIV-1 transcript
  • Tat-mediated HIV elongation arrest and recovery
  • TGFBR1 LBD Mutants in Cancer
  • RNA Polymerase II Pre-transcription Events
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • HIV elongation arrest and recovery
  • HIV Life Cycle
  • Generic Transcription Pathway
  • HIV Transcription Elongation
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • Loss of Function of SMAD2/3 in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Host Interactions of HIV factors
  • Loss of Function of SMAD4 in Cancer
  • Interactions of Tat with host cellular proteins
  • TGFBR1 KD Mutants in Cancer
  • Pausing and recovery of Tat-mediated HIV elongation
  • Loss of Function of TGFBR1 in Cancer
  • Late Phase of HIV Life Cycle
  • Formation of RNA Pol II elongation complex
  • Signaling by TGF-beta Receptor Complex
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Pausing and recovery of HIV elongation
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Transcription of the HIV genome
  • SMAD4 MH2 Domain Mutants in Cancer
  • RNA Polymerase II Transcription Elongation
  • Loss of Function of TGFBR2 in Cancer
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Signaling by Wnt
  • Cyclin E associated events during G1/S transition
  • binding of TCF/LEF:CTNNB1 to target gene promoters
  • TGFBR1 LBD Mutants in Cancer
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Generic Transcription Pathway
  • RNF mutants show enhanced WNT signaling and proliferation
  • G1/S Transition
  • Signaling by NOTCH1
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Mitotic G1-G1/S phases
  • FBXW7 Mutants and NOTCH1 in Cancer
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Loss of Function of SMAD2/3 in Cancer
  • Signaling by NOTCH
  • formation of the beta-catenin:TCF transactivating complex
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • S Phase
  • Cell Cycle, Mitotic
  • Loss of Function of TGFBR1 in Cancer
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • TCF dependent signaling in response to WNT
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Cyclin A:Cdk2-associated events at S phase entry
  • Signaling by WNT in cancer
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • SMAD4 MH2 Domain Mutants in Cancer
GTF2B and MYC general transcription factor IIB v-myc avian myelocytomatosis viral oncogene homolog
  • RNA Polymerase II Promoter Escape
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase II Transcription
  • HIV Infection
  • RNA Polymerase II Pre-transcription Events
  • Late Phase of HIV Life Cycle
  • HIV Life Cycle
  • HIV Transcription Initiation
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • RNA Polymerase II HIV Promoter Escape
  • RNA Polymerase II Transcription Initiation
  • Transcription of the HIV genome
  • Loss of Function of TGFBR2 in Cancer
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Signaling by Wnt
  • Cyclin E associated events during G1/S transition
  • binding of TCF/LEF:CTNNB1 to target gene promoters
  • TGFBR1 LBD Mutants in Cancer
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Generic Transcription Pathway
  • RNF mutants show enhanced WNT signaling and proliferation
  • G1/S Transition
  • Signaling by NOTCH1
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Mitotic G1-G1/S phases
  • FBXW7 Mutants and NOTCH1 in Cancer
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Loss of Function of SMAD2/3 in Cancer
  • Signaling by NOTCH
  • formation of the beta-catenin:TCF transactivating complex
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • S Phase
  • Cell Cycle, Mitotic
  • Loss of Function of TGFBR1 in Cancer
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • TCF dependent signaling in response to WNT
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Cyclin A:Cdk2-associated events at S phase entry
  • Signaling by WNT in cancer
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • SMAD4 MH2 Domain Mutants in Cancer
GTF2F1 and MYC general transcription factor IIF, polypeptide 1, 74kDa v-myc avian myelocytomatosis viral oncogene homolog
  • RNA Polymerase II Promoter Escape
  • mRNA Splicing
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase II Transcription
  • Abortive elongation of HIV-1 transcript in the absence of Tat
  • HIV Infection
  • Formation of the Early Elongation Complex
  • Tat-mediated elongation of the HIV-1 transcript
  • Tat-mediated HIV elongation arrest and recovery
  • RNA Pol II CTD phosphorylation and interaction with CE
  • RNA Polymerase II Pre-transcription Events
  • Influenza Life Cycle
  • HIV elongation arrest and recovery
  • HIV Transcription Initiation
  • HIV Life Cycle
  • RNA Pol II CTD phosphorylation and interaction with CE
  • Influenza Viral RNA Transcription and Replication
  • RNA Polymerase II HIV Promoter Escape
  • HIV Transcription Elongation
  • Processing of Capped Intron-Containing Pre-mRNA
  • mRNA Capping
  • mRNA Splicing - Minor Pathway
  • mRNA Splicing - Major Pathway
  • Influenza Infection
  • Pausing and recovery of Tat-mediated HIV elongation
  • Late Phase of HIV Life Cycle
  • Formation of RNA Pol II elongation complex
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • Pausing and recovery of HIV elongation
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of the HIV-1 Early Elongation Complex
  • Viral Messenger RNA Synthesis
  • RNA Polymerase II Transcription Initiation
  • Transcription of the HIV genome
  • RNA Polymerase II Transcription Elongation
  • Loss of Function of TGFBR2 in Cancer
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Signaling by Wnt
  • Cyclin E associated events during G1/S transition
  • binding of TCF/LEF:CTNNB1 to target gene promoters
  • TGFBR1 LBD Mutants in Cancer
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Generic Transcription Pathway
  • RNF mutants show enhanced WNT signaling and proliferation
  • G1/S Transition
  • Signaling by NOTCH1
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Mitotic G1-G1/S phases
  • FBXW7 Mutants and NOTCH1 in Cancer
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Loss of Function of SMAD2/3 in Cancer
  • Signaling by NOTCH
  • formation of the beta-catenin:TCF transactivating complex
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • S Phase
  • Cell Cycle, Mitotic
  • Loss of Function of TGFBR1 in Cancer
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • TCF dependent signaling in response to WNT
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Cyclin A:Cdk2-associated events at S phase entry
  • Signaling by WNT in cancer
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • SMAD4 MH2 Domain Mutants in Cancer
MYC and SKP1 v-myc avian myelocytomatosis viral oncogene homolog S-phase kinase-associated protein 1
  • Loss of Function of TGFBR2 in Cancer
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Signaling by Wnt
  • Cyclin E associated events during G1/S transition
  • binding of TCF/LEF:CTNNB1 to target gene promoters
  • TGFBR1 LBD Mutants in Cancer
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Generic Transcription Pathway
  • RNF mutants show enhanced WNT signaling and proliferation
  • G1/S Transition
  • Signaling by NOTCH1
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Mitotic G1-G1/S phases
  • FBXW7 Mutants and NOTCH1 in Cancer
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Loss of Function of SMAD2/3 in Cancer
  • Signaling by NOTCH
  • formation of the beta-catenin:TCF transactivating complex
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • S Phase
  • Cell Cycle, Mitotic
  • Loss of Function of TGFBR1 in Cancer
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • TCF dependent signaling in response to WNT
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Cyclin A:Cdk2-associated events at S phase entry
  • Signaling by WNT in cancer
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • SMAD4 MH2 Domain Mutants in Cancer
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Hedgehog 'off' state
  • misspliced GSK3beta mutants stabilize beta-catenin
  • T41 mutants of beta-catenin aren't phosphorylated
  • truncated APC mutants destabilize the destruction complex
  • TCF7L2 mutants don't bind CTBP
  • Cyclin E associated events during G1/S transition
  • Signaling by Wnt
  • Regulation of PLK1 Activity at G2/M Transition
  • Downstream signaling events of B Cell Receptor (BCR)
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Degradation of beta-catenin by the destruction complex
  • G1/S Transition
  • AXIN mutants destabilize the destruction complex, activating WNT signaling
  • S33 mutants of beta-catenin aren't phosphorylated
  • Signaling by NOTCH1 in Cancer
  • Prolactin receptor signaling
  • Mitotic G1-G1/S phases
  • truncations of AMER1 destabilize the destruction complex
  • Signaling by NOTCH
  • Host Interactions of HIV factors
  • phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
  • AXIN missense mutants destabilize the destruction complex
  • S45 mutants of beta-catenin aren't phosphorylated
  • Regulation of APC/C activators between G1/S and early anaphase
  • S Phase
  • Signaling by ERBB4
  • APC/C-mediated degradation of cell cycle proteins
  • Signaling by Interleukins
  • SCF(Skp2)-mediated degradation of p27/p21
  • deletions in the AMER1 gene destabilize the destruction complex
  • AMER1 mutants destabilize the destruction complex
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Interleukin-1 signaling
  • Cyclin A:Cdk2-associated events at S phase entry
  • SCF(Skp2)-mediated degradation of p27/p21
  • Mitotic G2-G2/M phases
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Adaptive Immune System
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • HIV Infection
  • APC truncation mutants have impaired AXIN binding
  • G2/M Transition
  • APC truncation mutants are not K63 polyubiquitinated
  • S37 mutants of beta-catenin aren't phosphorylated
  • Signaling by NOTCH1
  • Class I MHC mediated antigen processing & presentation
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling
  • FBXW7 Mutants and NOTCH1 in Cancer
  • Vpu mediated degradation of CD4
  • G1 Phase
  • Cytokine Signaling in Immune system
  • Cell Cycle, Mitotic
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Cyclin D associated events in G1
  • Nuclear signaling by ERBB4
  • Activation of NF-kappaB in B cells
  • SCF-beta-TrCP mediated degradation of Emi1
  • Regulation of mitotic cell cycle
  • Signaling by Hedgehog
  • deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling
  • Degradation of GLI1 by the proteasome
  • Signaling by WNT in cancer
  • GLI3 is processed to GLI3R by the proteasome
  • Degradation of GLI2 by the proteasome
MYC and TAF5 v-myc avian myelocytomatosis viral oncogene homolog TAF5 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 100kDa
  • Loss of Function of TGFBR2 in Cancer
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Signaling by Wnt
  • Cyclin E associated events during G1/S transition
  • binding of TCF/LEF:CTNNB1 to target gene promoters
  • TGFBR1 LBD Mutants in Cancer
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Generic Transcription Pathway
  • RNF mutants show enhanced WNT signaling and proliferation
  • G1/S Transition
  • Signaling by NOTCH1
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Mitotic G1-G1/S phases
  • FBXW7 Mutants and NOTCH1 in Cancer
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Loss of Function of SMAD2/3 in Cancer
  • Signaling by NOTCH
  • formation of the beta-catenin:TCF transactivating complex
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • S Phase
  • Cell Cycle, Mitotic
  • Loss of Function of TGFBR1 in Cancer
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • TCF dependent signaling in response to WNT
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Cyclin A:Cdk2-associated events at S phase entry
  • Signaling by WNT in cancer
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • SMAD4 MH2 Domain Mutants in Cancer
  • RNA Polymerase II Promoter Escape
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase II Transcription
  • HIV Infection
  • RNA Polymerase II Pre-transcription Events
  • Late Phase of HIV Life Cycle
  • HIV Life Cycle
  • HIV Transcription Initiation
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • RNA Polymerase II HIV Promoter Escape
  • RNA Polymerase II Transcription Initiation
  • Transcription of the HIV genome
MYC and TAF9 v-myc avian myelocytomatosis viral oncogene homolog TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa
  • Loss of Function of TGFBR2 in Cancer
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Signaling by Wnt
  • Cyclin E associated events during G1/S transition
  • binding of TCF/LEF:CTNNB1 to target gene promoters
  • TGFBR1 LBD Mutants in Cancer
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Generic Transcription Pathway
  • RNF mutants show enhanced WNT signaling and proliferation
  • G1/S Transition
  • Signaling by NOTCH1
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Mitotic G1-G1/S phases
  • FBXW7 Mutants and NOTCH1 in Cancer
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Loss of Function of SMAD2/3 in Cancer
  • Signaling by NOTCH
  • formation of the beta-catenin:TCF transactivating complex
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • S Phase
  • Cell Cycle, Mitotic
  • Loss of Function of TGFBR1 in Cancer
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • TCF dependent signaling in response to WNT
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Cyclin A:Cdk2-associated events at S phase entry
  • Signaling by WNT in cancer
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • SMAD4 MH2 Domain Mutants in Cancer
  • RNA Polymerase II Promoter Escape
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase II Transcription
  • Chromatin organization
  • HIV Infection
  • HATs acetylate histones
  • RNA Polymerase II Pre-transcription Events
  • Late Phase of HIV Life Cycle
  • HIV Life Cycle
  • HIV Transcription Initiation
  • Chromatin modifying enzymes
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • RNA Polymerase II HIV Promoter Escape
  • RNA Polymerase II Transcription Initiation
  • Transcription of the HIV genome
MYC and BTRC v-myc avian myelocytomatosis viral oncogene homolog beta-transducin repeat containing E3 ubiquitin protein ligase
  • Loss of Function of TGFBR2 in Cancer
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Signaling by Wnt
  • Cyclin E associated events during G1/S transition
  • binding of TCF/LEF:CTNNB1 to target gene promoters
  • TGFBR1 LBD Mutants in Cancer
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Generic Transcription Pathway
  • RNF mutants show enhanced WNT signaling and proliferation
  • G1/S Transition
  • Signaling by NOTCH1
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Mitotic G1-G1/S phases
  • FBXW7 Mutants and NOTCH1 in Cancer
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Loss of Function of SMAD2/3 in Cancer
  • Signaling by NOTCH
  • formation of the beta-catenin:TCF transactivating complex
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • S Phase
  • Cell Cycle, Mitotic
  • Loss of Function of TGFBR1 in Cancer
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • TCF dependent signaling in response to WNT
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Cyclin A:Cdk2-associated events at S phase entry
  • Signaling by WNT in cancer
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • SMAD4 MH2 Domain Mutants in Cancer
  • Signaling by the B Cell Receptor (BCR)
  • Hedgehog 'off' state
  • misspliced GSK3beta mutants stabilize beta-catenin
  • T41 mutants of beta-catenin aren't phosphorylated
  • TCF7L2 mutants don't bind CTBP
  • truncated APC mutants destabilize the destruction complex
  • Signaling by Wnt
  • Regulation of PLK1 Activity at G2/M Transition
  • Downstream signaling events of B Cell Receptor (BCR)
  • Degradation of beta-catenin by the destruction complex
  • AXIN mutants destabilize the destruction complex, activating WNT signaling
  • S33 mutants of beta-catenin aren't phosphorylated
  • RNF mutants show enhanced WNT signaling and proliferation
  • Prolactin receptor signaling
  • truncations of AMER1 destabilize the destruction complex
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
  • Host Interactions of HIV factors
  • AXIN missense mutants destabilize the destruction complex
  • S45 mutants of beta-catenin aren't phosphorylated
  • Regulation of APC/C activators between G1/S and early anaphase
  • Signaling by ERBB4
  • APC/C-mediated degradation of cell cycle proteins
  • Signaling by Interleukins
  • deletions in the AMER1 gene destabilize the destruction complex
  • AMER1 mutants destabilize the destruction complex
  • Interleukin-1 signaling
  • Mitotic G2-G2/M phases
  • Adaptive Immune System
  • Antigen processing: Ubiquitination & Proteasome degradation
  • APC truncation mutants have impaired AXIN binding
  • HIV Infection
  • G2/M Transition
  • deactivation of the beta-catenin transactivating complex
  • APC truncation mutants are not K63 polyubiquitinated
  • S37 mutants of beta-catenin aren't phosphorylated
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Class I MHC mediated antigen processing & presentation
  • Vpu mediated degradation of CD4
  • Cytokine Signaling in Immune system
  • Cell Cycle, Mitotic
  • Nuclear signaling by ERBB4
  • TCF dependent signaling in response to WNT
  • Activation of NF-kappaB in B cells
  • SCF-beta-TrCP mediated degradation of Emi1
  • Regulation of mitotic cell cycle
  • deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling
  • Signaling by Hedgehog
  • Degradation of GLI1 by the proteasome
  • Signaling by WNT in cancer
  • GLI3 is processed to GLI3R by the proteasome
  • Degradation of GLI2 by the proteasome
MYC and PAK2 v-myc avian myelocytomatosis viral oncogene homolog p21 protein (Cdc42/Rac)-activated kinase 2
  • Loss of Function of TGFBR2 in Cancer
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Signaling by Wnt
  • Cyclin E associated events during G1/S transition
  • binding of TCF/LEF:CTNNB1 to target gene promoters
  • TGFBR1 LBD Mutants in Cancer
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Generic Transcription Pathway
  • RNF mutants show enhanced WNT signaling and proliferation
  • G1/S Transition
  • Signaling by NOTCH1
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Mitotic G1-G1/S phases
  • FBXW7 Mutants and NOTCH1 in Cancer
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Loss of Function of SMAD2/3 in Cancer
  • Signaling by NOTCH
  • formation of the beta-catenin:TCF transactivating complex
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • S Phase
  • Cell Cycle, Mitotic
  • Loss of Function of TGFBR1 in Cancer
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • TCF dependent signaling in response to WNT
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Cyclin A:Cdk2-associated events at S phase entry
  • Signaling by WNT in cancer
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • SMAD4 MH2 Domain Mutants in Cancer
  • Regulation of PAK-2p34 activity by PS-GAP/RHG10
  • Costimulation by the CD28 family
  • Axon guidance
  • HIV Infection
  • FCERI mediated MAPK activation
  • VEGFA-VEGFR2 Pathway
  • Nef and signal transduction
  • Ephrin signaling
  • Activation of Rac
  • VEGFR2 mediated vascular permeability
  • Programmed Cell Death
  • EPH-Ephrin signaling
  • Innate Immune System
  • Generation of second messenger molecules
  • Semaphorin interactions
  • Apoptotic execution phase
  • CD28 co-stimulation
  • Regulation of activated PAK-2p34 by proteasome mediated degradation
  • Host Interactions of HIV factors
  • The role of Nef in HIV-1 replication and disease pathogenesis
  • CD28 dependent Vav1 pathway
  • Stimulation of the cell death response by PAK-2p34
  • TCR signaling
  • Signaling by VEGF
  • Sema3A PAK dependent Axon repulsion
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by Robo receptor
  • Regulation of Apoptosis
  • Adaptive Immune System
MYC and UBB v-myc avian myelocytomatosis viral oncogene homolog ubiquitin B
  • Loss of Function of TGFBR2 in Cancer
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Signaling by Wnt
  • Cyclin E associated events during G1/S transition
  • binding of TCF/LEF:CTNNB1 to target gene promoters
  • TGFBR1 LBD Mutants in Cancer
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Generic Transcription Pathway
  • RNF mutants show enhanced WNT signaling and proliferation
  • G1/S Transition
  • Signaling by NOTCH1
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Mitotic G1-G1/S phases
  • FBXW7 Mutants and NOTCH1 in Cancer
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Loss of Function of SMAD2/3 in Cancer
  • Signaling by NOTCH
  • formation of the beta-catenin:TCF transactivating complex
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • S Phase
  • Cell Cycle, Mitotic
  • Loss of Function of TGFBR1 in Cancer
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • TCF dependent signaling in response to WNT
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Cyclin A:Cdk2-associated events at S phase entry
  • Signaling by WNT in cancer
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • SMAD4 MH2 Domain Mutants in Cancer
  • Loss of Function of TGFBR2 in Cancer
  • NF-kB is activated and signals survival
  • Signaling by FGFR in disease
  • Hedgehog 'off' state
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Glucose metabolism
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Signaling by NOTCH1
  • Signaling by NOTCH2
  • Toll Like Receptor 5 (TLR5) Cascade
  • AXIN mutants destabilize the destruction complex, activating WNT signaling
  • S33 mutants of beta-catenin aren't phosphorylated
  • Stabilization of p53
  • Removal of licensing factors from origins
  • Switching of origins to a post-replicative state
  • Downregulation of ERBB2:ERBB3 signaling
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • Signaling by NOTCH
  • Endosomal Sorting Complex Required For Transport (ESCRT)
  • Spry regulation of FGF signaling
  • Signaling by NOTCH
  • SCF(Skp2)-mediated degradation of p27/p21
  • deletions in the AMER1 gene destabilize the destruction complex
  • Regulation of innate immune responses to cytosolic DNA
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Toll Like Receptor 3 (TLR3) Cascade
  • Metabolism of carbohydrates
  • CDK-mediated phosphorylation and removal of Cdc6
  • Cellular response to hypoxia
  • Hedgehog ligand biogenesis
  • p75NTR recruits signalling complexes
  • Fanconi Anemia pathway
  • Separation of Sister Chromatids
  • HIV Infection
  • APC truncation mutants have impaired AXIN binding
  • Assembly of the pre-replicative complex
  • Synthesis And Processing Of GAG, GAGPOL Polyproteins
  • Activated TLR4 signalling
  • S37 mutants of beta-catenin aren't phosphorylated
  • p53-Dependent G1 DNA Damage Response
  • regulation of FZD by ubiquitination
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Signaling by NOTCH1
  • p53-Independent DNA Damage Response
  • MyD88:Mal cascade initiated on plasma membrane
  • Stimuli-sensing channels
  • Membrane binding and targetting of GAG proteins
  • p53-Independent G1/S DNA damage checkpoint
  • G1/S DNA Damage Checkpoints
  • Downregulation of ERBB4 signaling
  • Vpu mediated degradation of CD4
  • Cell death signalling via NRAGE, NRIF and NADE
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • M/G1 Transition
  • p75 NTR receptor-mediated signalling
  • Signaling by FGFR
  • Toll Like Receptor 10 (TLR10) Cascade
  • Signaling by NOTCH1 in Cancer
  • TCF dependent signaling in response to WNT
  • SCF-beta-TrCP mediated degradation of Emi1
  • degradation of AXIN
  • Degradation of GLI1 by the proteasome
  • degradation of DVL
  • Cell Cycle Checkpoints
  • Signaling by WNT in cancer
  • GLI3 is processed to GLI3R by the proteasome
  • Regulation of Apoptosis
  • Degradation of GLI2 by the proteasome
  • Signaling by the B Cell Receptor (BCR)
  • Vif-mediated degradation of APOBEC3G
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Constitutive Signaling by NOTCH1 HD Domain Mutants
  • Downregulation of TGF-beta receptor signaling
  • truncated APC mutants destabilize the destruction complex
  • Cyclin E associated events during G1/S transition
  • TGF-beta receptor signaling activates SMADs
  • Regulation of PLK1 Activity at G2/M Transition
  • FCERI mediated NF-kB activation
  • Regulation of the Fanconi anemia pathway
  • Generic Transcription Pathway
  • G1/S Transition
  • Toll Like Receptor 9 (TLR9) Cascade
  • FBXW7 Mutants and NOTCH1 in Cancer
  • IRAK1 recruits IKK complex
  • Negative regulation of FGFR signaling
  • truncations of AMER1 destabilize the destruction complex
  • EGFR downregulation
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • IRAK2 mediated activation of TAK1 complex
  • Processing-defective Hh variants abrogate ligand secretion
  • Regulation of activated PAK-2p34 by proteasome mediated degradation
  • Host Interactions of HIV factors
  • phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
  • Signaling by ERBB4
  • Antiviral mechanism by IFN-stimulated genes
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Interleukin-3, 5 and GM-CSF signaling
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • M Phase
  • APC truncation mutants are not K63 polyubiquitinated
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
  • HIV Life Cycle
  • Budding and maturation of HIV virion
  • Hedgehog 'on' state
  • Programmed Cell Death
  • Class I MHC mediated antigen processing & presentation
  • IKK complex recruitment mediated by RIP1
  • MAP kinase activation in TLR cascade
  • Regulation of DNA replication
  • Cytokine Signaling in Immune system
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • MyD88-independent cascade
  • Cell Cycle, Mitotic
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Oxidative Stress Induced Senescence
  • Activation of NF-kappaB in B cells
  • Asymmetric localization of PCP proteins
  • deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling
  • TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling
  • IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
  • TRAF6 mediated induction of TAK1 complex
  • Negative regulators of RIG-I/MDA5 signaling
  • misspliced GSK3beta mutants stabilize beta-catenin
  • Hh ligand biogenesis disease
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • T41 mutants of beta-catenin aren't phosphorylated
  • Cellular Senescence
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by EGFRvIII in Cancer
  • Assembly Of The HIV Virion
  • Downstream signaling events of B Cell Receptor (BCR)
  • Degradation of beta-catenin by the destruction complex
  • NOD1/2 Signaling Pathway
  • Glycogen storage diseases
  • MyD88 dependent cascade initiated on endosome
  • Mitotic G1-G1/S phases
  • activated TAK1 mediates p38 MAPK activation
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • TRIF-mediated TLR3/TLR4 signaling
  • DNA Replication Pre-Initiation
  • Senescence-Associated Secretory Phenotype (SASP)
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • TGFBR1 KD Mutants in Cancer
  • S45 mutants of beta-catenin aren't phosphorylated
  • Regulation of APC/C activators between G1/S and early anaphase
  • Late Phase of HIV Life Cycle
  • APC/C:Cdc20 mediated degradation of Cyclin B
  • NOTCH2 Activation and Transmission of Signal to the Nucleus
  • TCR signaling
  • AMER1 mutants destabilize the destruction complex
  • Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
  • Interleukin-1 signaling
  • APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
  • PCP/CE pathway
  • Mitotic G2-G2/M phases
  • Adaptive Immune System
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Regulation of Hypoxia-inducible Factor (HIF) by oxygen
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • Ubiquitin-dependent degradation of Cyclin D
  • G2/M Transition
  • TGFBR1 LBD Mutants in Cancer
  • Oncogene Induced Senescence
  • Autodegradation of Cdh1 by Cdh1:APC/C
  • Ion channel transport
  • p75NTR signals via NF-kB
  • Regulation of signaling by CBL
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Disease
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Signal Transduction
  • Innate Immune System
  • Synthesis of DNA
  • Loss of Function of SMAD2/3 in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • G1 Phase
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • Loss of Function of TGFBR1 in Cancer
  • Ubiquitin-dependent degradation of Cyclin D1
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Toll-Like Receptors Cascades
  • Cyclin D associated events in G1
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • Regulation of mitotic cell cycle
  • Signaling by Hedgehog
  • Association of licensing factors with the pre-replicative complex
  • IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
  • Ubiquitin Mediated Degradation of Phosphorylated Cdc25A
  • TCF7L2 mutants don't bind CTBP
  • p53-Dependent G1/S DNA damage checkpoint
  • Signaling by Wnt
  • AUF1 (hnRNP D0) destabilizes mRNA
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • APC/C:Cdc20 mediated degradation of Securin
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • CDK-mediated phosphorylation and removal of Cdc6
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • IRAK1 recruits IKK complex
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • RNF mutants show enhanced WNT signaling and proliferation
  • Myoclonic epilepsy of Lafora
  • Signaling by NOTCH1 in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • IRAK2 mediated activation of TAK1 complex
  • Loss of Function of SMAD4 in Cancer
  • AXIN missense mutants destabilize the destruction complex
  • S Phase
  • APC/C-mediated degradation of cell cycle proteins
  • Toll Like Receptor 2 (TLR2) Cascade
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by Interleukins
  • Glycogen synthesis
  • NRIF signals cell death from the nucleus
  • Toll Like Receptor 4 (TLR4) Cascade
  • Signaling by EGFR in Cancer
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • SCF(Skp2)-mediated degradation of p27/p21
  • Cyclin A:Cdk2-associated events at S phase entry
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Mitotic Metaphase and Anaphase
  • Downstream TCR signaling
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Orc1 removal from chromatin
  • Mitotic Anaphase
  • deactivation of the beta-catenin transactivating complex
  • Toll Like Receptor TLR6:TLR2 Cascade
  • MyD88 cascade initiated on plasma membrane
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • FBXW7 Mutants and NOTCH1 in Cancer
  • JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
  • Signalling by NGF
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Cytosolic sensors of pathogen-associated DNA
  • beta-catenin independent WNT signaling
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Orc1 removal from chromatin
  • Signaling by TGF-beta Receptor Complex
  • CDT1 association with the CDC6:ORC:origin complex
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • SMAD4 MH2 Domain Mutants in Cancer

Page 2 out of 266 pages